Production of adjuvants
Ended Awarded Last action
- Contract number
- HHSN27200006
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,458,937
Award facts
- Opportunity
-
- NIHAI2015035 Solicitation number
- Contract value 100% obligated
- $1,458,936.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | -$1 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $78,739 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Original award | $1,380,198 |
About this award
This federal contract award is for the PRODUCTION OF ADJUVANTS by Advanced Bioscience Laboratories, Inc. (ABL), a for-profit organization and manufacturer of goods. The contract, valued at $1,458,936.50, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type, with an ultimate completion date of April 15, 2025. This contract is not associated with a set-aside designation. ABL has been awarded numerous federal contracts and grants, particularly from NIH and HHS, to advance the development of medical countermeasures for various infectious diseases and other health conditions. The company holds several Indefinite Delivery Vehicles (IDVs) with federal agencies, demonstrating its broad capabilities in biopharmaceutical research and development.
Quick answers
Who was awarded contract HHSN27200006?
HHSN27200006 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 21, 2017.
How much is contract HHSN27200006 worth?
The government has obligated $1,458,937 on HHSN27200006.
Is contract HHSN27200006 an order under another contract?
Yes. HHSN27200006 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract HHSN27200006 competed?
The extent of competition for HHSN27200006 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award